Article Information
History
- October 26, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ling Xie1,†,
- Ryan N. Sheehy3,†,
- Yan Xiong5,†,
- Adil Muneer1,†,
- John A. Wrobel1,
- Kwang-Su Park5,
- Julia Velez5,
- Jing Liu5,
- Yan-Jia Luo3,4,
- Ya-Dong Li3,4,
- Luis Quintanilla3,4,
- Yongyi Li3,
- Chongchong Xu6,
- Mohanish Deshmukh4,7,
- Zhexing Wen6,
- Jian Jin5,*,
- Juan Song3,4,* and
- Xian Chen1,2,*,‡
- 1Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
- 2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
- 3Department of Pharmacology, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
- 4Neuroscience Center, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
- 5Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer, Institute, Icahn School of Medicine at Mount Sinai; New York, NY 10029, USA
- 6Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurology, Emory University School of Medicine; Atlanta, GA 30322, USA
- 7Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill; Chapel Hill, NC 27599, USA
- ↵*Corresponding author. Email: xianc{at}email.unc.edu (X.C.); juansong{at}email.unc.edu (J.S.); jian.jin{at}mssm.edu (J.J.)
↵† These Authors contributed equally.
Posted October 26, 2023.
Novel brain-penetrant inhibitor of G9a methylase blocks Alzheimer’s disease proteopathology for precision medication
